Form 8-K - Current report:
SEC Accession No. 0000950170-25-072792
Filing Date
2025-05-15
Accepted
2025-05-15 16:49:09
Documents
15
Period of Report
2025-05-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sldb-20250515.htm   iXBRL 8-K 46730
2 EX-5.1 sldb-ex5_1.htm EX-5.1 21030
3 GRAPHIC img14594897_0.jpg GRAPHIC 1961
4 GRAPHIC img14594897_1.jpg GRAPHIC 266724
5 GRAPHIC img14594897_2.jpg GRAPHIC 1579
  Complete submission text file 0000950170-25-072792.txt   555682

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sldb-20250515.xsd EX-101.SCH 23888
17 EXTRACTED XBRL INSTANCE DOCUMENT sldb-20250515_htm.xml XML 4528
Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38360 | Film No.: 25954704
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)